A detailed history of Hbk Investments L P transactions in Exact Sciences Corp stock. As of the latest transaction made, Hbk Investments L P holds 93,100 shares of EXAS stock, worth $4.93 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
93,100
Holding current value
$4.93 Million
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $258,033 - $383,688
2,755 Added 60.28%
7,325 $911,000
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $3.38 Million - $4.49 Million
-28,954 Reduced 86.37%
4,570 $602,000
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $1.27 Million - $2.35 Million
33,524 New
33,524 $2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.